Sea Crest Wealth Management, LLC Endra Life Sciences Inc. Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$1.02 - $2.04 $19,704 - $39,408	-19,318 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$1.65 - $3.29 $167,141 - $333,270	-101,298 Reduced 83.98%	19,318 $32,000
Q4 2018 Feb 13, 2019	BUY	$1.5 - $5.4 $23,718 - $85,384	15,812 Added 15.09%	120,616 $181,000
Q3 2018 Nov 14, 2018	BUY	$1.94 - $3.57 $25,138 - $46,260	12,958 Added 14.11%	104,804 $321,000
Q2 2018 Aug 03, 2018	BUY	$1.61 - $2.9 $147,872 - $266,353	91,846 New	91,846 $234,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $322M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.